NCT00903201 · Interventional trial
28 Day Repeat Dose in Cystic Fibrosis Patients
Overall registry status Completed
Phase 2
Conditions Cystic Fibrosis
Delaware Valley sites
- GSK Investigational Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory